The Psychopharmacology of Aggressive Behavior

Pagadala, 2009, Aripiprazole for psychosis-induced aggression or agitation (protocol)., Cochrane Database Syst Rev, 4, CD008074

Comai, 2012, The psychopharmacology of aggressive behavior: a translational approach. Part 1: Neurobiology., J Clin Psychopharmacol, 32, 83, 10.1097/JCP.0b013e31823f8770

Fava, 1997, Psychopharmacologic treatment of pathologic aggression., Psychiatr Clin North Am, 20, 427, 10.1016/S0193-953X(05)70321-X

Goedhard, 2006, . Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: a systematic review., J Clin Psychiatry, 67, 1013, 10.4088/JCP.v67n0702

Stewart, 1990, . A review of the pharmacotherapy of aggression in children and adolescents., J Am Acad Child Adolesc Psychiatry, 29, 269, 10.1097/00004583-199003000-00017

Gillies, 2005, . Benzodiazepines for psychosis-induced aggression or agitation., Cochrane Database Syst Rev, 4, CD003079

Barratt, 1993, The use of anticonvulsants in aggression and violence., Psychopharmacol Bull, 29, 75

Huband, 2010, . Antiepileptics for aggression and associated impulsivity., Cochrane Database Syst Rev, 2, CD003499

Hughes, 1999, Acute psychopharmacological management of the aggressive psychotic patient., Psychiatr Serv, 50, 1135, 10.1176/ps.50.9.1135

Weisman, 1998, Effects of clorazepate, diazepam, and oxazepam on a laboratory measurement of aggression in men., Int Clin Psychopharmacol, 13, 183, 10.1097/00004850-199807000-00005

Fava, 1993, Psychopharmacology of pathologic aggression., Harv Rev Psychiatry, 1, 244, 10.3109/10673229309017085

Coccaro, 1997, Fluoxetine and impulsive aggressive behavior in personality-disordered subjects., Arch Gen Psychiatry, 54, 1081, 10.1001/archpsyc.1997.01830240035005

Beaulieu, 2009, AktGSK3 signaling in the action of psychotropic drugs., Annu Rev Pharmacol Toxicol, 49, 327, 10.1146/annurev.pharmtox.011008.145634

Collett, 2003, Ten-year review of rating scales. VI: Scales assessing externalizing behaviors., J Am Acad Child Adolesc Psychiatry, 42, 1143, 10.1097/00004583-200310000-00006

Suris, 2004, . Measures of aggressive behavior: overview of clinical and research instruments., Aggress Violent Behav, 9, 165, 10.1016/S1359-1789(03)00012-0

Yudofsky, 1986, . The Overt Aggression Scale for the objective rating of verbal and physical aggression., Am J Psychiatry, 143, 35, 10.1176/ajp.143.1.35

Kay, 1988, Profiles of aggression among psychiatric patients. I. Nature and prevalence., J Nerv Ment Dis, 176, 539, 10.1097/00005053-198809000-00007

Kemph, 1993, . Treatment of aggressive children with clonidine: results of an open pilot study., J Am Acad Child Adolesc Psychiatry, 32, 577, 10.1097/00004583-199305000-00013

Coccaro, 1991, . Development of neuropharmacologically based behavioral assessments of impulsive aggressive behavior., J Neuropsychiatry Clin Neurosci, 3, S44

Buss, 1957, An inventory for assessing different kinds of hostility., J Consult Psychol, 21, 343, 10.1037/h0046900

Kay, 1987, The Positive and Negative Syndrome Scale (PANSS) for schizophrenia., Schizophr Bull, 13, 261, 10.1093/schbul/13.2.261

Overall, 1982, The Brief Psychiatric Rating Scale for children., Psychopharmacol Bull, 18, 10

Shapiro, 2003, . Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology., Neuropsychopharmacology, 28, 1400, 10.1038/sj.npp.1300203

Stark, 2007, . Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT2A receptors: functional receptor-binding and in vivo electrophysiological studies., Psychopharmacology (Berl), 190, 373, 10.1007/s00213-006-0621-y

Zhang, 2006, . Distinct functional profiles of aripiprazole and olanzapine at RNA edited human 5-HT2C receptor isoforms., Biochem Pharmacol, 71, 521, 10.1016/j.bcp.2005.11.007

Davies, 2004, Aripiprazole: a novel atypical antipsychotic drug with a uniquely robust pharmacology., CNS Drug Rev, 10, 317, 10.1111/j.1527-3458.2004.tb00030.x

Lawler, 1999, . Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes., Neuropsychopharmacology, 20, 612, 10.1016/S0893-133X(98)00099-2

Ishii, 2010, . Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway., Neurosci Lett, 471, 53, 10.1016/j.neulet.2010.01.010

Andrezina, 2006, . Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study., Curr Med Res Opin, 22, 2209, 10.1185/030079906X148445

Frye, 2008, . Aripiprazole efficacy in irritability and disruptive-aggressive symptoms: young mania rating scale line analysis from two, randomized, double-blind, placebo-controlled trials., J Clin Psychopharmacol, 28, 243, 10.1097/JCP.0b013e31816745f7

Kinon, 2008, . Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia., J Clin Psychopharmacol, 28, 601, 10.1097/JCP.0b013e31818aaf6c

Marcus, 2009, . A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder., J Am Acad Child Adolesc Psychiatry, 48, 1110, 10.1097/CHI.0b013e3181b76658

Nickel, 2006, . Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study., Am J Psychiatry, 163, 833, 10.1176/ajp.2006.163.5.833

Nickel, 2007, Aripiprazole treatment of patients with borderline personality disorder., J Clin Psychiatry, 68, 1815, 10.4088/JCP.v68n1124f

Owen, 2009, . Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder., Pediatrics, 124, 1533, 10.1542/peds.2008-3782

Tran-Johnson, 2007, . Efficacy and safety of intramuscular aripiprazole in patients with acute agitation: a randomized, double-blind, placebo-controlled trial., J Clin Psychiatry, 68, 111, 10.4088/JCP.v68n0115

Lea, 2007, Agitation associated with aripiprazole initiation., Pharmacotherapy, 27, 1339, 10.1592/phco.27.9.1339

Iqbal, 2003, . Clozapine: a clinical review of adverse effects and management., Ann Clin Psychiatry, 15, 33, 10.3109/10401230309085668

Van Tol, 1991, . Cloning of the gene for a human dopamine D4-receptor with high-affinity for the antipsychotic clozapine., Nature, 350, 610, 10.1038/350610a0

Ashby, 1996, Pharmacological actions of the atypical antipsychotic drug clozapine: a review., Synapse, 24, 349, 10.1002/(SICI)1098-2396(199612)24:4<349::AID-SYN5>3.0.CO;2-D

Olianas, 1997, Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor., Br J Pharmacol, 122, 401, 10.1038/sj.bjp.0701357

Cochran, 2002, . Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol., Neuropharmacology, 43, 394, 10.1016/S0028-3908(02)00091-6

Toua, 2010, . The effects of sub-chronic clozapine and haloperidol administration on isolation rearing induced changes in frontal cortical N-methyl-D-aspartate and D1 receptor binding in rats., Neuroscience, 165, 492, 10.1016/j.neuroscience.2009.10.039

Krakowski, 2006, . Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder., Arch Gen Psychiatry, 63, 622, 10.1001/archpsyc.63.6.622

Volavka, 2004, . Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol., J Clin Psychopharmacol, 24, 225, 10.1097/01.jcp.0000117424.05703.29

Bitter, 2005, . Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO)., Eur Psychiatry, 20, 403, 10.1016/j.eurpsy.2005.01.009

Buckley, 1999, The role of typical and atypical antipsychotic medications in the management of agitation and aggression., J Clin Psychiatry, 60, 52

Stahl, 1999, Selecting an atypical antipsychotic by combining clinical experience with guidelines from clinical trials., J Clin Psychiatry, 60, 31

Glazer, 1999, Does loxapine have atypical properties Clinical evidence., J Clin Psychiatry, 60, 42

Singh, 1996, . A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes., J Psychiatry Neurosci, 21, 29

Rauser, 2001, . Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor., J Pharmacol Exp Ther, 299, 83

Ereshefsky, 1999, Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic., J Clin Psychiatry, 60, 20

Fruensgaard, 1977, . Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study., Acta Psychiatr Scand, 56, 256, 10.1111/j.1600-0447.1977.tb00226.x

Moyano, 1975, A double-blind comparison of loxitane-loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients., Dis Nerv Syst, 36, 301

Paprocki, 1977, A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia., Curr Ther Res Clin Exp, 21, 80

Selman, 1976, Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics., Curr Ther Res Clin Exp, 19, 645

Tuason, 1986, A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients., J Clin Psychiatry, 47, 126

Reinblatt, 2006, . Loxapine treatment in an autistic child with aggressive behavior: therapeutic challenges., J Child Adolesc Psychopharmacol, 16, 639, 10.1089/cap.2006.16.639

Pilowsky, 1996, . Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapinea 123I IBZM single photon emission tomography (SPET) study., Psychopharmacology (Berl), 124, 148, 10.1007/BF02245615

Bymaster, 1999, . Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro., Schizophr Res, 37, 107, 10.1016/S0920-9964(98)00146-7

Gobbi, 2001, Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour., J Psychiatry Neurosci, 26, 340

Bymaster, 2003, . Muscarinic mechanisms of antipsychotic atypicality., Prog Neuropsychopharmacol Biol Psychiatry, 27, 1125, 10.1016/j.pnpbp.2003.09.008

Locchi, 2008, . Olanzapine counteracts stress-induced anxiety-like behavior in rats., Neurosci Lett, 438, 146, 10.1016/j.neulet.2008.04.017

Girgenti, 2010, . Antipsychotic-induced gene regulation in multiple brain regions., J Neurochem, 113, 175, 10.1111/j.1471-4159.2010.06585.x

Bogenschutz, 2004, Olanzapine versus placebo in the treatment of borderline personality disorder., J Clin Psychiatry, 65, 104, 10.4088/JCP.v65n0118

Breier, 2002, . A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia., Arch Gen Psychiatry, 59, 441, 10.1001/archpsyc.59.5.441

Linehan, 2008, . Olanzapine plus dialectical behavior therapy for women with high irritability who meet criteria for borderline personality disorder: a double-blind, placebo-controlled pilot study., J Clin Psychiatry, 69, 999, 10.4088/JCP.v69n0617

Meehan, 2001, . A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania., J Clin Psychopharmacol, 21, 389, 10.1097/00004714-200108000-00006

Shafti, 2010, Olanzapine versus haloperidol in the management of borderline personality disorder: a randomized double-blind trial., J Clin Psychopharmacol, 30, 44, 10.1097/JCP.0b013e3181c826ff

Soler, 2005, . Double-blind, placebo-controlled study of dialectical behavior therapy plus olanzapine for borderline personality disorder., Am J Psychiatry, 162, 1221, 10.1176/appi.ajp.162.6.1221

Wang, 2006, . Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study., J Psychiatr Res, 40, 669, 10.1016/j.jpsychires.2006.03.008

Wright, 2001, . Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia., Am J Psychiatry, 158, 1149, 10.1176/appi.ajp.158.7.1149

Zanarini, 2001, Olanzapine treatment of female borderline personality disorder patients: a double-blind, placebo-controlled pilot study., J Clin Psychiatry, 62, 849, 10.4088/JCP.v62n1103

Zanarini, 2004, A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder., J Clin Psychiatry, 65, 903, 10.4088/JCP.v65n0704

Richelson, 2000, Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds., Life Sci, 68, 29, 10.1016/S0024-3205(00)00911-5

Newman-Tancredi, 1998, . Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a 35SGTPS binding study., Eur J Pharmacol, 355, 245, 10.1016/S0014-2999(98)00483-X

Orsetti, 2009, . Some molecular effectors of antidepressant action of quetiapine revealed by DNA microarray in the frontal cortex of anhedonic rats., Pharmacogenet Genomics, 19, 600, 10.1097/FPC.0b013e32832ee573

Barzman, 2006, . The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s)., J Child Adolesc Psychopharmacol, 16, 665, 10.1089/cap.2006.16.665

Bowden, 2005, . A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder., J Clin Psychiatry, 66, 111, 10.4088/JCP.v66n0116

Buckley, 2007, Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine., J Affect Disord, 100, S33, 10.1016/j.jad.2007.02.005

Connor, 2008, Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder., J Child Adolesc Psychopharmacol, 18, 140, 10.1089/cap.2006.0007

McIntyre, 2005, . Quetiapine or haloperidol as monotherapy for bipolar maniaa 12-week, double-blind, randomised, parallel-group, placebo-controlled trial., Eur Neuropsychopharmacol, 15, 573, 10.1016/j.euroneuro.2005.02.006

Sachs, 2004, . Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study., Bipolar Disord, 6, 213, 10.1111/j.1399-5618.2004.00115.x

Yatham, 2004, . Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania., J Clin Psychopharmacol, 24, 599, 10.1097/01.jcp.0000144887.66319.2f

Leysen, 1988, . Biochemical profile of risperidone, a new antipsychotic., J Pharmacol Exp Ther, 247, 661

Fang, 1999, Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4., Naunyn Schmiedebergs Arch Pharmacol, 359, 147, 10.1007/PL00005334

Schwartzer, 2009, . Paliperidone suppresses the development of the aggressive phenotype in a developmentally sensitive animal model of escalated aggression., Psychopharmacology (Berl), 203, 653, 10.1007/s00213-008-1412-4

Megens, 1994, . Survey on the pharmacodynamics of the new antipsychotic risperidone., Psychopharmacology (Berl), 114, 9, 10.1007/BF02245439

Aman, 2005, . Acute and long-term safety and tolerability of risperidone in children with autism., J Child Adolesc Psychopharmacol, 15, 869, 10.1089/cap.2005.15.869

Armenteros, 2007, Risperidone augmentation for treatment-resistant aggression in attention-deficithyperactivity disorder: a placebo-controlled pilot study., J Am Acad Child Adolesc Psychiatry, 46, 558, 10.1097/chi.0b013e3180323354

De Deyn, 2006, Risperidone in the management of agitation and aggression associated with psychiatric disorders., Eur Psychiatry, 21, 21, 10.1016/j.eurpsy.2005.11.003

McDougle, 1998, . A double-blind, placebo-controlled study of risperidone in adults with autistic disorder and other pervasive developmental disorders., Arch Gen Psychiatry, 55, 633, 10.1001/archpsyc.55.7.633

LeBlanc, 2005, . Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials., Int Clin Psychopharmacol, 20, 275, 10.1097/01.yic.0000166403.03732.72

Monnelly, 2003, . Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder., J Clin Psychopharmacol, 23, 193, 10.1097/00004714-200304000-00012

Nagaraj, 2006, Risperidone in children with autism: randomized, placebo-controlled, double-blind study., J Child Neurol, 21, 450, 10.1177/08830738060210060801

Tyrer, 2008, . Risperidone, haloperidol, and placebo in the treatment of aggressive challenging behaviour in patients with intellectual disability: a randomised controlled trial., Lancet, 371, 57, 10.1016/S0140-6736(08)60072-0

Veser, 2006, . Risperidone versus haloperidol, in combination with lorazepam, in the treatment of acute agitation and psychosis: a pilot, randomized, double-blind, placebo-controlled trial., J Psychiatr Pract, 12, 103, 10.1097/00131746-200603000-00005

Findling, 2000, . A double-blind pilot study of risperidone in the treatment of conduct disorder., J Am Acad Child Adolesc Psychiatry, 39, 509, 10.1097/00004583-200004000-00021

Buitelaar, 2001, . A randomized controlled trial of risperidone in the treatment of aggression in hospitalized adolescents with subaverage cognitive abilities., J Clin Psychiatry, 62, 239, 10.4088/JCP.v62n0405

Van Bellinghen, 2001, Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial., J Child Adolesc Psychopharmacol, 11, 5, 10.1089/104454601750143348

Snyder, 2002, . Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs., J Am Acad Child Adolesc Psychiatry, 41, 1026, 10.1097/00004583-200209000-00002

Aman, 2002, . Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence., Am J Psychiatry, 159, 1337, 10.1176/appi.ajp.159.8.1337

McCracken, 2002, . Risperidone in children with autism and serious behavioral problems., N Engl J Med, 347, 314, 10.1056/NEJMoa013171

Shea, 2004, . Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders., Pediatrics, 114, e634, 10.1542/peds.2003-0264-F

Czobor, 1995, Effect of risperidone on hostility in schizophrenia., J Clin Psychopharmacol, 15, 243, 10.1097/00004714-199508000-00002

Blin, 1996, Antipsychotic and anxiolytic properties of risperidone, haloperidol, and methotrimeprazine in schizophrenic patients., J Clin Psychopharmacol, 16, 38, 10.1097/00004714-199602000-00007

Segal, 1998, Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial., Clin Neuropharmacol, 21, 176

Citrome, 2001, . Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia., Psychiatr Serv, 52, 1510, 10.1176/appi.ps.52.11.1510

Sachs, 2002, . Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety., Am J Psychiatry, 159, 1146, 10.1176/appi.ajp.159.7.1146

Yatham, 2003, . Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial., Br J Psychiatry, 182, 141, 10.1192/bjp.182.2.141

Currier, 2004, . Acute treatment of psychotic agitation: a randomized comparison of oral treatment with risperidone and lorazepam versus intramuscular treatment with haloperidol and lorazepam., J Clin Psychiatry, 65, 386, 10.4088/JCP.v65n0315

Citrome, 2007, . Risperidone alone versus risperidone plus valproate in the treatment of patients with schizophrenia and hostility., Int Clin Psychopharmacol, 22, 356, 10.1097/YIC.0b013e3281c61baf

Seeger, 1995, . Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity., J Pharmacol Exp Ther, 275, 101

Tatsumi, 1999, . Pharmacological profile of neuroleptics at human monoamine transporters., Eur J Pharmacol, 368, 277, 10.1016/S0014-2999(99)00005-9

Daniel, 2001, . Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial., Psychopharmacology (Berl), 155, 128, 10.1007/s002130000658

Lesem, 2001, . Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients., J Clin Psychiatry, 62, 12, 10.4088/JCP.v62n0104

Pascual, 2008, . Ziprasidone in the treatment of borderline personality disorder: a double-blind, placebo-controlled, randomized study., J Clin Psychiatry, 69, 603, 10.4088/JCP.v69n0412

Scott, 2009, . Agitation andor aggression after traumatic brain injury in the pediatric population treated with ziprasidone. Clinical article., J Neurosurg Pediatr, 3, 484, 10.3171/2009.2.PEDS08292

Bastiaens, 2009, A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic., Community Ment Health J, 45, 73, 10.1007/s10597-008-9154-7

Scatton, 1997, . Amisulpride: from animal pharmacology to therapeutic action., Int Clin Psychopharmacol, 12, S29, 10.1097/00004850-199705002-00006

Pani, 2002, The substituted benzamides and their clinical potential on dysthymia and on the negative symptoms of schizophrenia., Mol Psychiatr, 7, 247, 10.1038/sj.mp.4001040

Di Giovanni, 1998, . Effects of acute and repeated administration of amisulpride, a dopamine D-2D-3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons., J Pharmacol Exp Ther, 287, 51

Abbas, 2009, . Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo., Psychopharmacology (Berl), 205, 119, 10.1007/s00213-009-1521-8

Muller, 2002, . Dose-related effects of amisulpride on five dimensions of psychopathology in patients with acute exacerbation of schizophrenia., J Clin Psychopharmacol, 22, 554, 10.1097/00004714-200212000-00004

Mann, 1984, . Amisulpridean open clinical study of a new benzamide in schizophrenic patients., Pharmacopsychiatry, 17, 111, 10.1055/s-2007-1017419

Mauri, 2006, . Amisulpride in the treatment of behavioural disturbances among patients with moderate to severe Alzheimers disease., Acta Neurol Scand, 114, 97, 10.1111/j.1600-0404.2006.00660.x

Gordey, 2000, Differential sensitivity of recombinant GABA(A) receptors expressed in Xenopus oocytes to modulation by topiramate., Epilepsia, 41, S25, 10.1111/j.1528-1157.2000.tb02167.x

Herrero, 2002, . Two new actions of topiramate: inhibition of depolarizing GABA(A)-mediated responses and activation of a potassium conductance., Neuropharmacology, 42, 210, 10.1016/S0028-3908(01)00171-X

Poulsen, 2004, . Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons., Neurochem Res, 29, 275, 10.1023/B:NERE.0000010456.92887.3b

Shank, 2008, Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate., CNS Neurosci Ther, 14, 120, 10.1111/j.1527-3458.2008.00041.x

Gobbi, 2006, Efficacy of topiramate, valproate, and their combination on aggressionagitation behavior in patients with psychosis., J Clin Psychopharmacol, 26, 467, 10.1097/01.jcp.0000237945.35022.45

Janowsky, 2003, . Effects of topiramate on aggressive, self-injurious, and disruptivedestructive behaviors in the intellectually disabled: an open-label retrospective study., J Clin Psychopharmacol, 23, 500, 10.1097/01.jcp.0000088906.24613.76

Kuo, 2010, Topiramate in treatment of tourette syndrome., Clin Neuropharmacol, 33, 32, 10.1097/WNF.0b013e3181c295c1

Lane, 2009, . Acute topiramate differentially affects human aggressive responding at low vs. moderate doses in subjects with histories of substance abuse and antisocial behavior., Pharmacol Biochem Behav, 92, 357, 10.1016/j.pbb.2009.01.002

Loew, 2006, . Topiramate treatment for women with borderline personality disorder: a double-blind, placebo-controlled study., J Clin Psychopharmacol, 26, 61, 10.1097/01.jcp.0000195113.61291.48

Mula, 2003, . Topiramate and psychiatric adverse events in patients with epilepsy., Epilepsia, 44, 659, 10.1046/j.1528-1157.2003.05402.x

Nickel, 2004, . Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study., J Clin Psychiatry, 65, 1515, 10.4088/JCP.v65n1112

Nickel, 2005, . Treatment of aggression with topiramate in male borderline patients: a double-blind, placebo-controlled study., Biol Psychiatry, 57, 495, 10.1016/j.biopsych.2004.11.044

Nickel, 2005, . Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study., J Affect Disord, 87, 243, 10.1016/j.jad.2005.04.003

Nickel, 2007, Topiramate reduced aggression in female patients with borderline personality disorder., Eur Arch Psychiatry Clin Neurosci, 257, 432, 10.1007/s00406-007-0735-1

Nickel, 2008, Treatment of aggression with topiramate in male borderline patients. Part II: 18-month follow-up., Eur Psychiatry, 23, 115, 10.1016/j.eurpsy.2007.09.004

Janowsky, 2003, Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial., J Clin Psychiatry, 64, 1258, 10.4088/JCP.v64n1018

Meunier, 1963, . Pharmacodynamic properties of N-dipropylacetic acid in French., Therapie, 18, 435

Hering, 1992, Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo., Cephalalgia, 12, 81, 10.1046/j.1468-2982.1992.1202081.x

Regan, 1985, Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin., Brain Res, 347, 394, 10.1016/0006-8993(85)90207-0

Johannessen, 2000, Mechanisms of action of valproate: a commentatory., Neurochem Int, 37, 103, 10.1016/S0197-0186(00)00013-9

Zeise, 1991, Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro., Brain Res, 544, 345, 10.1016/0006-8993(91)90078-A

Gean, 1994, . Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices., Brain Res Bull, 33, 333, 10.1016/0361-9230(94)90202-X

Gobbi, 2006, Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex., Psychopharmacology (Berl), 185, 255, 10.1007/s00213-006-0317-3

Slater, 1978, Sodium valproate increases potassium conductance in aplysia neurons., Epilepsia, 19, 379, 10.1111/j.1528-1157.1978.tb04504.x

Perlman, 1984, Membrane-disordering potency and anticonvulsant action of valproic acid and other short-chain fatty acids., Mol Pharmacol, 26, 83

Monti, 2009, Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection., Curr Mol Pharmacol, 2, 95, 10.2174/1874467210902010095

Batty, 2009, Histone deacetylase inhibitors as anti-neoplastic agents., Cancer Lett, 280, 192, 10.1016/j.canlet.2009.03.013

Citrome, 2004, . Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone., Psychiatr Serv, 55, 290, 10.1176/appi.ps.55.3.290

DelBello, 2004, Divalproex for the treatment of aggression associated with adolescent mania., J Child Adolesc Psychopharmacol, 14, 325, 10.1089/1044546041649101

Donovan, 2000, . Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design., Am J Psychiatry, 157, 818, 10.1176/appi.ajp.157.5.818

Hellings, 2005, . A double-blind, placebo-controlled study of valproate for aggression in youth with pervasive developmental disorders., J Child Adolesc Psychopharmacol, 15, 682, 10.1089/cap.2005.15.682

Hollander, 2001, . A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder., J Clin Psychiatry, 62, 199, 10.4088/JCP.v62n0311

Hollander, 2003, . Divalproex in the treatment of impulsive aggression: efficacy in cluster B personality disorders., Neuropsychopharmacology, 28, 1186, 10.1038/sj.npp.1300153

Hollander, 2005, . Impact of trait impulsivity and state aggression on divalproex versus placebo response in borderline personality disorder., Am J Psychiatry, 162, 621, 10.1176/appi.ajp.162.3.621

Stanford, 2005, . A comparison of anticonvulsants in the treatment of impulsive aggression., Exp Clin Psychopharmacol, 13, 72, 10.1037/1064-1297.13.1.72

Miller, 1986, . Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I. Anticonvulsant profile in mice and rats., Epilepsia, 27, 483, 10.1111/j.1528-1157.1986.tb03572.x

Calabrese, 1996, Antidepressant effects of lamotrigine in rapid cycling bipolar disorder., Am J Psychiatry, 153, 1236, 10.1176/ajp.153.9.1236a

Dursun, 1999, Clozapine plus lamotrigine in treatment-resistant schizophrenia., Arch Gen Psychiatry, 56, 950, 10.1001/archpsyc.56.10.950

Finnerup, 2002, . Lamotrigine in spinal cord injury pain: a randomized controlled trial., Pain, 96, 375, 10.1016/S0304-3959(01)00484-5

Silver, 2007, . Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain., J Pain Symptom Manage, 34, 446, 10.1016/j.jpainsymman.2006.12.015

Kuo, 1997, Characterization of lamotrigine inhibition of Na channels in rat hippocampal neurones., Br J Pharmacol, 121, 1231, 10.1038/sj.bjp.0701221

Huang, 2004, . Inhibitory effect of lamotrigine on A-type potassium current in hippocampal neuron-derived H19-7 cells., Epilepsia, 45, 729, 10.1111/j.0013-9580.2004.58403.x

Leach, 1986, Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action., Epilepsia, 27, 490, 10.1111/j.1528-1157.1986.tb03573.x

Hahn, 2004, . The current understanding of lamotrigine as a mood stabilizer., J Clin Psychiatry, 65, 791, 10.4088/JCP.v65n0610

Lee, 2008, . Chronic administration of lamotrigine downregulates COX-2 mRNA and protein in rat frontal cortex., Neurochem Res, 33, 861, 10.1007/s11064-007-9526-3

Cunningham, 2000, The anticonvulsant, lamotrigine decreases spontaneous glutamate release but increases spontaneous GABA release in the rat entorhinal cortex in vitro., Neuropharmacology, 39, 2139, 10.1016/S0028-3908(00)00051-4

Waldmeier, 1995, . Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters., Neurology, 45, 1907, 10.1212/WNL.45.10.1907

Beran, 1998, Aggressive behaviour in intellectually challenged patients with epilepsy treated with lamotrigine., Epilepsia, 39, 280, 10.1111/j.1528-1157.1998.tb01373.x

Chang, 2006, An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression., J Am Acad Child Adolesc Psychiatry, 45, 298, 10.1097/01.chi.0000194566.86160.a3

Labiner, 2009, . Effects of lamotrigine compared with levetiracetam on anger, hostility, and total mood in patients with partial epilepsy., Epilepsia, 50, 434, 10.1111/j.1528-1167.2008.01792.x

Leiberich, 2008, . Lamotrigine treatment of aggression in female borderline patients. Part II: An 18-month follow-up., J Psychopharmacol, 22, 805, 10.1177/0269881107084004

Tritt, 2005, . Lamotrigine treatment of aggression in female borderline-patients: a randomized, double-blind, placebo-controlled study., J Psychopharmacol, 19, 287, 10.1177/0269881105051540

Whitworth, 2001, Upregulation of gamma-aminobutyric acid transporter expression: role of alkylated gamma-aminobutyric acid derivatives., Biochem Soc Trans, 29, 736, 10.1042/bst0290736

Goldlust, 1995, . Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA., Epilepsy Res, 22, 1, 10.1016/0920-1211(95)00028-9

Ng, 2001, . gamma-Aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action., Mol Pharmacol, 59, 144, 10.1124/mol.59.1.144

Taylor, 1998, . A summary of mechanistic hypotheses of gabapentin pharmacology., Epilepsy Res, 29, 233, 10.1016/S0920-1211(97)00084-3

Jensen, 2002, . The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors., Mol Pharmacol, 61, 1377, 10.1124/mol.61.6.1377

Suarez, 2005, . Presynaptic NMDA autoreceptors facilitate axon excitability: a new molecular target for the anticonvulsant gabapentin., Eur J Neurosci, 21, 197, 10.1111/j.1460-9568.2004.03832.x

Maneuf, 2001, Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase., Br J Pharmacol, 134, 237, 10.1038/sj.bjp.0704227

Striano, 2008, Gabapentin: a Ca2 channel alpha 2-delta ligand far beyond epilepsy therapy., Drugs Today (Barc), 44, 353, 10.1358/dot.2008.44.5.1186403

Cherek, 2004, . Acute effects of gabapentin on laboratory measures of aggressive and escape responses of adult parolees with and without a history of conduct disorder., Psychopharmacology, 171, 405, 10.1007/s00213-003-1590-z

2003, F, SantAnna MK, Vianna MRM, et al.. Effects of gabapentin on anxiety induced by simulated public speaking., J Psychopharmacol, 17, 184, 10.1177/0269881103017002006

Lee, 1996, . Behavioral side effects of gabapentin in children., Epilepsia, 37, 87, 10.1111/j.1528-1157.1996.tb00517.x

Pinninti, 2001, Gabapentin-associated aggression., J Neuropsychiatry Clin Neurosci, 13, 424, 10.1176/jnp.13.3.424

Tallian, 1996, . Gabapentin associated with aggressive behavior in pediatric patients with seizures., Epilepsia, 37, 501, 10.1111/j.1528-1157.1996.tb00598.x

Wolf, 1995, . Gabapentin toxicity in children manifesting as behavioral changes., Epilepsia, 36, 1203, 10.1111/j.1528-1157.1995.tb01063.x

Tondo, 2009, Long-term lithium treatment in the prevention of suicidal behavior in bipolar disorder patients., Epidemiol Psichiatr Soc, 18, 179, 10.1017/S1121189X00000439

Geddes, 2004, . Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials., Am J Psychiatry, 161, 217, 10.1176/appi.ajp.161.2.217

Sheard, 1970, Neuronally activated metabolism of brain serotonin: effect of lithium., Life Sci, 9, 285, 10.1016/0024-3205(70)90030-5

Sheard, 1970, Effect of lithium on foot shock aggression in rats., Nature, 228, 284, 10.1038/228284a0

Sheard, 1971, Effect of lithium on human aggression., Nature, 230, 113, 10.1038/230113a0

Blier, 1985, Short-term lithium administration enhances serotonergic neurotransmission: electrophysiological evidence in the rat CNS., Eur J Pharmacol, 113, 69, 10.1016/0014-2999(85)90344-9

Wada, 2005, . Lithium: potential therapeutics against acute brain injuries and chronic neurodegenerative diseases., J Pharmacol Sci, 99, 307, 10.1254/jphs.CRJ05009X

Nonaka, 1998, Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx., Proc Natl Acad Sci U S A, 95, 2642, 10.1073/pnas.95.5.2642

Kameda, 2001, . Effects of lithium on dopamine D2 receptor expression in the rat brain striatum., J Neural Transm, 108, 321, 10.1007/s007020170078

Young, 2009, Review of lithium effects on brain and blood., Cell Transplant, 18, 951, 10.3727/096368909X471251

Leng, 2008, . Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition., J Neurosci, 28, 2576, 10.1523/JNEUROSCI.5467-07.2008

Fatemi, 2009, The role of lithium in modulation of brain genes: relevance for aetiology and treatment of bipolar disorder., Biochem Soc Trans, 37, 1090, 10.1042/BST0371090

Beaulieu, 2008, Looking at lithium: molecular moods and complex behaviour., Mol Interv, 8, 230, 10.1124/mi.8.5.8

Pasquali, 2010, . Intracellular pathways underlying the effects of lithium., Behav Pharmacol, 21, 473, 10.1097/FBP.0b013e32833da5da

Campbell, 1984, . Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder., Arch Gen Psychiatry, 41, 650, 10.1001/archpsyc.1984.01790180020002

Campbell, 1995, . Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study., J Am Acad Child Adolesc Psychiatry, 34, 445, 10.1097/00004583-199504000-00011

Craft, 1987, . Lithium in the treatment of aggression in mentally handicapped patients. A double-blind trial., Br J Psychiatry, 150, 685, 10.1192/bjp.150.5.685

Dickstein, 2009, . Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation., J Child Adolesc Psychopharmacol, 19, 61, 10.1089/cap.2008.044

Dorrego, 2002, . A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficithyperactivity disorder: preliminary findings., J Neuropsychiatry Clin Neurosci, 14, 289, 10.1176/jnp.14.3.289

Kafantaris, 2003, . Lithium treatment of acute mania in adolescents: a large open trial., J Am Acad Child Adolesc Psychiatry, 42, 1038, 10.1097/01.CHI.0000070247.24125.24

Lee, 1992, . A trial of lithium citrate for the management of acute agitation of psychiatric inpatientsa pilot study., J Clin Psychopharmacol, 12, 361, 10.1097/00004714-199210000-00015

Malone, 2000, . A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder., Arch Gen Psychiatry, 57, 649, 10.1001/archpsyc.57.7.649

Masi, 2009, . Effectiveness of lithium in children and adolescents with conduct disorder: a retrospective naturalistic study., CNS Drugs, 23, 59, 10.2165/0023210-200923010-00004

Rifkin, 1997, . Lithium treatment of conduct disorders in adolescents., Am J Psychiatry, 154, 554, 10.1176/ajp.154.4.554

Sheard, 1976, . The effect of lithium on impulsive aggressive behavior in man., Am J Psychiatry, 133, 1409, 10.1176/ajp.133.12.1409

Worrall, 1975, Lithium in non-manic-depressives: antiaggressive effect and red blood cell lithium values., Br J Psychiatry, 126, 464, 10.1192/bjp.126.5.464

Lopez-Larson, 2006, Empirical evidence for the use of lithium and anticonvulsants in children with psychiatric disorders., Harv Rev Psychiatry, 14, 285, 10.1080/10673220601082869

Newcomer, 2007, Metabolic considerations in the use of antipsychotic medications: a review of recent evidence., J Clin Psychiatry, 68, 20

Kasteng, 2011, . Metabolic effects and cost-effectiveness in aripiprazole versus olanzapine in schizophrenia and bipolar disorder., Acta Psychiatr Scand, 124, 214, 10.1111/j.1600-0447.2011.01716.x

Miczek, 2002, . Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and gamma-aminobutyric acid systems., Psychopharmacology (Berl), 163, 434, 10.1007/s00213-002-1139-6

Gobbi, 2003, What is a recommended treatment for raggression in a patient with schizophrenia J Psychiatry Neurosci., , 28, 320

Kapur, 2000, . Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia., Am J Psychiatry, 157, 514, 10.1176/appi.ajp.157.4.514

Kapur, 1999, Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia., Am J Psychiatry, 156, 286, 10.1176/ajp.156.2.286

Rainer, 2004, . Zotepine for behavioural and psychological symptoms in dementia: an open-label study., CNS Drugs, 18, 49, 10.2165/00023210-200418010-00005

Sato, 2006, . Efficacy of perospirone in the management of aggressive behavior associated with dementia., Prog Neuropsychopharmacol Biol Psychiatry, 30, 679, 10.1016/j.pnpbp.2006.01.028

Redolat, 1991, Sulpiride has an antiaggressive effect in mice without markedly depressing motor activity., Neuropharmacology, 30, 41, 10.1016/0028-3908(91)90040-I